Glenview Capital's Q3 13F filing reveals increased stakes in Meta and Teva, reductions in CVS and Block, and full exits from Dick's Sporting Goods and STM.
Seeking Alpha
3 stories shown
Glenview Capital's Q3 13F filing reveals increased stakes in Meta and Teva, reductions in CVS and Block, and full exits from Dick's Sporting Goods and STM.
The FDA approved Teva Pharmaceutical Industries' IGALMI sublingual film for at-home use in treating acute agitation associated with schizophrenia and bipolar disorder.
Teva received FDA approval for an at-home indication of Igalmi to treat agitation associated with schizophrenia and other disorders.